Gene Editing Cell Line Generation Service Market
Gene Editing Cell Line Generation Service Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Gene Editing Cell Line Generation Service Market Size and Growth
The Gene Editing Cell Line Generation Service market is poised for significant growth, driven by advancements in CRISPR technology and increasing demand for customized cell lines in research and therapeutics. The market size is projected to reach approximately $1.9 billion by 2025, reflecting a compound annual growth rate (CAGR) of 15%.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ 'Thermo Fisher Scientific'
◍ 'Merck'
◍ 'OriGene'
◍ 'Taconic Biosciences'
◍ 'Creative Bioarray'
◍ 'Horizon Discovery'
◍ 'Synthego'
◍ 'Applied Biological Materials'
◍ 'Cyagen'
◍ 'Cellecta'
◍ 'BiologicsCorp'
◍ 'Kyinno Bio'
◍ 'Applied StemCell'
◍ 'Creative Biogene'
◍ 'Porton Advanced'
◍ 'Cytosurge'
◍ 'AcceGen'
◍ 'System Biosciences'
The Gene Editing Cell Line Generation Service Market features key players like Thermo Fisher Scientific, Merck, and Horizon Discovery, offering CRISPR and related technologies to enhance research capabilities. These companies drive market growth by providing tailored services, fostering innovation, and expanding applications in pharmaceuticals and biotechnology.
- Thermo Fisher Scientific: ~$35 billion (2022)
- Merck: ~$24 billion (2022)
- Horizon Discovery: ~$147 million (2022)
Request Sample Report
Market Segmentation
By Application
◍ 'Academic and Research Institutions'
By Product
◍ 'CRISPR/Cas9'
◍ 'Pharmaceutical and Biotechnology Companies' Request Sample Report
◍ 'TALEN'
◍ 'Others'
Market Growth
Request Sample Report
$ X Billion USD
